IDEXX Laboratories Aktie
WKN: 888210 / ISIN: US45168D1046
|
03.11.2025 12:44:54
|
IDEXX Laboratories Inc Q3 Profit Increases, Beats Estimates
(RTTNews) - IDEXX Laboratories Inc (IDXX) announced earnings for its third quarter that Increased from the same period last year and beat the Street estimates.
The company's earnings totaled $274.61 million, or $3.40 per share. This compares with $232.84 million, or $2.80 per share, last year.
Excluding items, IDEXX Laboratories Inc reported adjusted earnings of $3.22 per share for the period.
Analysts on average had expected the company to earn $3.14 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 13.3% to $1.105 billion from $975.54 million last year.
IDEXX Laboratories Inc earnings at a glance (GAAP) :
-Earnings: $274.61 Mln. vs. $232.84 Mln. last year. -EPS: $3.40 vs. $2.80 last year. -Revenue: $1.105 Bln vs. $975.54 Mln last year.
-Guidance: Full year EPS guidance: $12.81 - $13.01 Full year revenue guidance: $4,270 - $4,300 Mln
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu IDEXX Laboratoriesmehr Nachrichten
Analysen zu IDEXX Laboratoriesmehr Analysen
Aktien in diesem Artikel
| IDEXX Laboratories | 590,40 | -0,84% |
|